Anti-Glucose Transporter GLUT3 antibody (ab15311)

Publishing research using ab15311? Please let us know so that we can cite the reference in this datasheet.

ab15311 has been referenced in 19 publications.

  • Kuang R  et al. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight 2:e88815 (2017). WB ; Human . PubMed: 28138554
  • Mai WX  et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med 23:1342-1351 (2017). PubMed: 29035366
  • Birsoy K  et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508:108-12 (2014). PubMed: 24670634
  • Vittori A  et al. Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease. Hum Mol Genet N/A:N/A (2014). WB ; Human . PubMed: 24452335
  • McKinnon B  et al. Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions. J Mol Endocrinol 52:169-79 (2014). PubMed: 24412827
  • Caro-Maldonado A  et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol 192:3626-36 (2014). PubMed: 24616478
  • Kaira K  et al. Biological correlation of ¹8F-FDG uptake on PET in pulmonary neuroendocrine tumors. Anticancer Res 33:4219-28 (2013). IHC ; Human . PubMed: 24122985
  • Roy M  et al. Long-term calorie restriction has minimal impact on brain metabolite and fatty acid profiles in aged rats on a Western-style diet. Neurochem Int 63:450-7 (2013). Rat . PubMed: 23974047
  • Kim JE  et al. Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab Anim Res 28:181-91 (2012). WB ; Rat . PubMed: 23091518
  • Kaira K  et al. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma. Eur J Cancer 48:1244-54 (2012). PubMed: 22330319
  • Kaira K  et al. LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer. Am J Transl Res 3:468-78 (2011). PubMed: 22046488
  • Kaira K  et al. Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumors. Oncol Rep 26:931-7 (2011). PubMed: 21750865
  • Lee YK  et al. Differential regulation of the biosynthesis of glucose transporters by the PI3-K and MAPK pathways of insulin signaling by treatment with novel compounds from Liriope platyphylla. Int J Mol Med 27:319-27 (2011). WB ; Mouse . PubMed: 21165549
  • Medina Villaamil V  et al. Fructose transporter GLUT5 expression in clear renal cell carcinoma. Oncol Rep 25:315-23 (2011). IHC-P ; Human . PubMed: 21165569
  • Kaira K  et al. Correlation Between 18F-FDG Uptake on PET and Molecular Biology in Metastatic Pulmonary Tumors. J Nucl Med 52:705-11 (2011). PubMed: 21498541
  • Delgado T  et al. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci U S A 107:10696-701 (2010). WB ; Human . PubMed: 20498071
  • Kaira K  et al. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746-53 (2010). Human . PubMed: 20625125
  • Wei LH  et al. Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma. Clin Cancer Res 14:3416-26 (2008). WB ; Human . PubMed: 18519772
  • Agrawal A  et al. Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. Am J Physiol Cell Physiol 293:C621-31 (2007). PubMed: 17442734


Sign up